First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype

Saito Yoshimasa; Serizawa Hiroshi; Kato Yukako; Nakano Masaru; Nakamura Masahiko; Saito Hidetsugu; Suzuki Hidekazu; Kanai Takanori

首页> 外文期刊>World journal of gastroenterology : >First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype

【24h】

First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype

机译：CYP2C19基因型影响基于埃索美拉唑的三联疗法根除幽门螺杆菌阳性胃炎的一线治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AIM: To evaluate the effect of first line esomeprazole (EPZ)-based triple therapy on Helicobacter pylori (H. pylori) eradication.

机译：目的：评估基于一线埃索美拉唑（EPZ）的三联疗法对幽门螺杆菌（H. pylori）根除的效果。

著录项

来源
《World journal of gastroenterology :》 |2015年第48期|共7页
作者
Saito Yoshimasa; Serizawa Hiroshi; Kato Yukako; Nakano Masaru; Nakamura Masahiko; Saito Hidetsugu; Suzuki Hidekazu; Kanai Takanori;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词
CYP2C19; Esomeprazole; Helicobacter pylori; Pepsinogen; Proton pump inhibitor;

机译：CYP2C19;埃索美拉唑;幽门螺杆菌;胃蛋白酶原;质子泵抑制剂;

相似文献

外文文献
中文文献
专利

1. First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype [J] . Saito Yoshimasa, Serizawa Hiroshi, Kato Yukako, World journal of gastroenterology : . 2015,第48期

机译：CYP2C19基因型影响基于埃索美拉唑的三联疗法根除幽门螺杆菌阳性胃炎的一线治疗
2. Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in chinese adults. [J] . Pan X, Li Y, Qiu Y, Clinical therapeutics . 2010,第12期

机译：左氧氟沙星和阿莫西林联合埃索美拉唑或雷贝拉唑一线三联疗法根除幽门螺杆菌感染和CYP2C19基因型的疗效和耐受性：这项为期1周的针对中国成年人的随机，开放性研究。
3. Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: a 1-week, randomized, open-label study in chinese adults. [J] . Pan X, Li Y, Qiu Y, Clinical therapeutics . 2010,第12期

机译：左氧氟沙星和阿莫西林联合埃索美拉唑或雷贝拉唑一线三联疗法根除幽门螺杆菌感染和CYP2C19基因型的疗效和耐受性：这项为期1周的针对中国成年人的随机，开放性研究。
4. Major influence of CYP2C19 genotype on the steady-state concentration of N~desmethylclobazam [C] . T. Takahashi Korean Child Neurology Society Congress . 2009

机译：CYP2C19基因型对N〜Desmethylbobazam稳态浓度的主要影响
5. Secondary analysis of effectivness of tinidazole-containing-quadruple eradication therapy in asymptomatic Helicobacter pylori infected children in El Paso [D] . Prieto-Jimenez, Carmen Aida 2010

机译：EL Pyliancational幽门螺杆菌幽门螺杆菌幽门术中含锡咪唑类含有四肢切除治疗的有效性的二次分析
6. First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype [O] . Yoshimasa Saito, Hiroshi Serizawa, Yukako Kato, 2015

机译：CYP2C19基因型影响基于埃索美拉唑的三联疗法根除幽门螺杆菌阳性胃炎的一线治疗
7. How to Proceed in Helicobacter pylori-Positive Chronic Gastritis Refractory to First- and Second-Line Eradication Therapy [O] . Dino Vaira, Chiara Ricci, Alberto Lanzini, 2007

机译：如何在幽门螺杆菌中进行，慢性慢性胃炎难以进行第一和二线根除治疗

First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype

摘要

著录项

相似文献

相关主题

期刊订阅